Tenofovir alafenamide nephrotoxicity: a case report and literature review

BACKGROUND: Tenofovir alafenamide (TAF), a novel prodrug of tenofovir (TFV), has become the preferred drug for the treatment of HIV-1 and chronic hepatitis B infection in clinical practice. Results from clinical trials showed that it had better renal and bone mineral outcomes compared to tenofovir d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueaphongsukkit, Thornthun, Gatechompol, Sivaporn, Avihingsanon, Anchalee, Surintrspanont, Jerasit, Iampenkhae, Kroonpong, Avihingsanon, Yingyos, Udomkarnjananun, Suwasin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379835/
https://www.ncbi.nlm.nih.gov/pubmed/34419091
http://dx.doi.org/10.1186/s12981-021-00380-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379835/
https://www.ncbi.nlm.nih.gov/pubmed/34419091
http://dx.doi.org/10.1186/s12981-021-00380-w

Ejemplares similares